Overview

This retrospective monocentric study evaluates adherence to international clinical practice guidelines for soft tissue sarcoma management in Strasbourg and its impact on overall survival. It also compares practices and outcomes between two periods (2010-2016 and 2017-2024).

Eligibility

Inclusion Criteria:

• Patient aged 18 years or older at first multidisciplinary tumor board presentation
• Presented for multidisciplinary tumor board evaluation for soft tissue or visceral tumor
• First presentation between 01/01/2017 and 31/12/2024
• Absence of opposition to reuse of medical data for research purposes

Exclusion Criteria:

• Presence of opposition to reuse of medical data for research purposes
• Patient younger than 18 years at first presentation
• Bone tumors, gastrointestinal stromal tumors (GIST), or Kaposi sarcoma
• First presentation outside the study period
• Management outside Alsace-Moselle
• Duplicate records